310 related articles for article (PubMed ID: 31412296)
1. SOX2 in development and cancer biology.
Novak D; Hüser L; Elton JJ; Umansky V; Altevogt P; Utikal J
Semin Cancer Biol; 2020 Dec; 67(Pt 1):74-82. PubMed ID: 31412296
[TBL] [Abstract][Full Text] [Related]
2. Linking Pluripotency Reprogramming and Cancer.
Iglesias JM; Gumuzio J; Martin AG
Stem Cells Transl Med; 2017 Feb; 6(2):335-339. PubMed ID: 28191771
[TBL] [Abstract][Full Text] [Related]
3. The multiple roles for Sox2 in stem cell maintenance and tumorigenesis.
Liu K; Lin B; Zhao M; Yang X; Chen M; Gao A; Liu F; Que J; Lan X
Cell Signal; 2013 May; 25(5):1264-71. PubMed ID: 23416461
[TBL] [Abstract][Full Text] [Related]
4. SIX2 Mediates Late-Stage Metastasis via Direct Regulation of
Oliphant MUJ; Vincent MY; Galbraith MD; Pandey A; Zaberezhnyy V; Rudra P; Johnson KR; Costello JC; Ghosh D; DeGregori J; Espinosa JM; Ford HL
Cancer Res; 2019 Feb; 79(4):720-734. PubMed ID: 30606720
[TBL] [Abstract][Full Text] [Related]
5. SOX2 in cancer stemness: tumor malignancy and therapeutic potentials.
Mamun MA; Mannoor K; Cao J; Qadri F; Song X
J Mol Cell Biol; 2020 Feb; 12(2):85-98. PubMed ID: 30517668
[TBL] [Abstract][Full Text] [Related]
6. The dark side of SOX2: cancer - a comprehensive overview.
Wuebben EL; Rizzino A
Oncotarget; 2017 Jul; 8(27):44917-44943. PubMed ID: 28388544
[TBL] [Abstract][Full Text] [Related]
7. SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells.
Rybak AP; Tang D
Cell Signal; 2013 Dec; 25(12):2734-42. PubMed ID: 24036214
[TBL] [Abstract][Full Text] [Related]
8. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
[TBL] [Abstract][Full Text] [Related]
9. LncRNA MALAT1 increases the stemness of gastric cancer cells via enhancing SOX2 mRNA stability.
Xiao Y; Pan J; Geng Q; Wang G
FEBS Open Bio; 2019 Jul; 9(7):1212-1222. PubMed ID: 31037832
[TBL] [Abstract][Full Text] [Related]
10. Targeting SOX2 in anticancer therapy.
Hüser L; Novak D; Umansky V; Altevogt P; Utikal J
Expert Opin Ther Targets; 2018 Dec; 22(12):983-991. PubMed ID: 30366514
[TBL] [Abstract][Full Text] [Related]
11. MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer.
Jiang J; Li Z; Yu C; Chen M; Tian S; Sun C
Cancer Lett; 2015 Jan; 356(2 Pt B):962-70. PubMed ID: 25444909
[TBL] [Abstract][Full Text] [Related]
12. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
[No Abstract] [Full Text] [Related]
13. SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma.
Boumahdi S; Driessens G; Lapouge G; Rorive S; Nassar D; Le Mercier M; Delatte B; Caauwe A; Lenglez S; Nkusi E; Brohée S; Salmon I; Dubois C; del Marmol V; Fuks F; Beck B; Blanpain C
Nature; 2014 Jul; 511(7508):246-50. PubMed ID: 24909994
[TBL] [Abstract][Full Text] [Related]
14. SOX2 protein biochemistry in stemness, reprogramming, and cancer: the PI3K/AKT/SOX2 axis and beyond.
Schaefer T; Lengerke C
Oncogene; 2020 Jan; 39(2):278-292. PubMed ID: 31477842
[TBL] [Abstract][Full Text] [Related]
15. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
Yan ZY; Sun XC
Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
[No Abstract] [Full Text] [Related]
16. The FBXW2-MSX2-SOX2 axis regulates stem cell property and drug resistance of cancer cells.
Yin Y; Xie CM; Li H; Tan M; Chen G; Schiff R; Xiong X; Sun Y
Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20528-20538. PubMed ID: 31548378
[TBL] [Abstract][Full Text] [Related]
17. SOX2 and p53 Expression Control Converges in PI3K/AKT Signaling with Versatile Implications for Stemness and Cancer.
Schaefer T; Steiner R; Lengerke C
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664542
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA miR-590-5p inhibits breast cancer cell stemness and metastasis by targeting SOX2.
Zhou L; Zhao LC; Jiang N; Wang XL; Zhou XN; Luo XL; Ren J
Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):87-94. PubMed ID: 28121351
[TBL] [Abstract][Full Text] [Related]
19. Regulation of colorectal carcinoma stemness, growth, and metastasis by an miR-200c-Sox2-negative feedback loop mechanism.
Lu YX; Yuan L; Xue XL; Zhou M; Liu Y; Zhang C; Li JP; Zheng L; Hong M; Li XN
Clin Cancer Res; 2014 May; 20(10):2631-42. PubMed ID: 24658157
[TBL] [Abstract][Full Text] [Related]
20. AKT drives SOX2 overexpression and cancer cell stemness in esophageal cancer by protecting SOX2 from UBR5-mediated degradation.
Wang Z; Kang L; Zhang H; Huang Y; Fang L; Li M; Brown PJ; Arrowsmith CH; Li J; Wong J
Oncogene; 2019 Jun; 38(26):5250-5264. PubMed ID: 30894683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
